Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)
Trial details
- Registry ID
- NCT07660094
- Drugs studied
- Aglatimagene Besadenovec, Docetaxel, Pembrolizumab, Valacyclovir